Cargando…

Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation

High-risk cornea transplant recipients represent a patient population with significant un-met medical need for more effective therapies to prevent immunological graft rejection due to heightened anti-donor immune response. In this study, a rat model of pre-existing anti-donor immunity was developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohan, Paul, Murphy, Nick, Treacy, Oliver, Lynch, Kevin, Morcos, Maurice, Chen, Bingling, Ryan, Aideen E., Griffin, Matthew D., Ritter, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255848/ https://www.ncbi.nlm.nih.gov/pubmed/30515159 http://dx.doi.org/10.3389/fimmu.2018.02666

Ejemplares similares

Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
por: Treacy, Oliver, et al.
Publicado: (2021)

Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?
por: Lohan, Paul, et al.
Publicado: (2017)

TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo
por: Lynch, Kevin, et al.
Publicado: (2020)

Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?
por: Lohan, Paul, et al.
Publicado: (2014)

Mesenchymal stem cells avoid allogeneic rejection
por: Ryan, Jennifer M, et al.
Publicado: (2005)

Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)

A comprehensive flow-cytometric analysis of graft infiltrating lymphocytes, draining lymph nodes and serum during the rejection phase in a fully allogeneic rat cornea transplant model
por: Maenz, Martin, et al.
Publicado: (2011)

Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
por: Lynch, Kevin, et al.
Publicado: (2017)

Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation
por: Treacy, Oliver, et al.
Publicado: (2012)

Third-party JavaScript
por: Vinegar, Ben, et al.
Publicado: (2013)

Payment to a third party
Publicado: (1992)

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
por: Jiang, Wei, et al.
Publicado: (2022)

Managing third-party software for the LCG
por: Poinsignon, E, et al.
Publicado: (2005)

Third-party punishment by preverbal infants
por: Kanakogi, Yasuhiro, et al.
Publicado: (2022)

Emergence of specialized third-party enforcement
por: Mohlin, Erik, et al.
Publicado: (2023)

Third Parties Mirror the Aggression of the Antagonists: A Video-Based Analysis of Third-Party Aggression in Interpersonal Conflicts
por: Ejbye-Ernst, Peter, et al.
Publicado: (2021)

Immune response to allogeneic equine mesenchymal stromal cells
por: Kamm, J. Lacy, et al.
Publicado: (2021)

‘To quarterback behind the scenes, third-party efforts’: the tobacco industry and the Tea Party
por: Fallin, Amanda, et al.
Publicado: (2014)

Web Runner 2049: Evaluating Third-Party Anti-bot Services
por: Amin Azad, Babak, et al.
Publicado: (2020)

The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection
por: Jia, Zhe, et al.
Publicado: (2018)

Immunopathogenesis of corneal graft rejection
por: Maharana, Prafulla Kumar, et al.
Publicado: (2023)

Fourth-Party Evaluation of Third-Party Pro-social Help and Punishment: An ERP Study
por: Li, Jianbiao, et al.
Publicado: (2018)

Benchmarking third-party-transfer protocols with the FTS
por: Dona, Rizart
Publicado: (2018)

Third-party transfers in WLCG using HTTP
por: Bockelman, Brian, et al.
Publicado: (2020)

Defectors, not norm violators, are punished by third-parties
por: Bone, Jonathan, et al.
Publicado: (2014)

Commentary: The Emerging Neuroscience of Third-Party Punishment
por: Zinchenko, Oksana, et al.
Publicado: (2017)

The motivational basis of third-party punishment in children
por: Twardawski, Mathias, et al.
Publicado: (2020)

The Impact of Third Party Reproduction on Family and Kinship
por: Behjati Ardakani, Zohreh, et al.
Publicado: (2021)

Orchestration of autonomous trusted third-party banking
por: Muthaiyah, Saravanan, et al.
Publicado: (2021)

A strong case for third-party testing
por: Lund-Johansen, Fridtjof
Publicado: (2023)

Peripheral blood immune cell profiling of acute corneal transplant rejection
por: Hjortdal, Jesper, et al.
Publicado: (2022)

Corneal Allograft Rejection: Immunopathogenesis to Therapeutics
por: Qazi, Yureeda, et al.
Publicado: (2013)

Management and prevention of corneal graft rejection
por: Mandal, Sohini, et al.
Publicado: (2023)

Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
por: O'Malley, Grace, et al.
Publicado: (2016)

Effect of allogeneic mesenchymal stem cells (MSCs) on corneal wound healing in dogs
por: Falcão, Mário Sérgio Almeida, et al.
Publicado: (2019)

XRootD Third Party Copy for the WLCG and HLLHC
por: Adye, T, et al.
Publicado: (2020)

Sex, Attractiveness, and Third-Party Punishment in Fairness Consideration
por: Li, Jia, et al.
Publicado: (2014)

Enactment of Third-Party Punishment by 4-Year-Olds
por: Kenward, Ben, et al.
Publicado: (2012)

The effect of altruistic tendency on fairness in third-party punishment
por: Sun, Lu, et al.
Publicado: (2015)

Third-Party Coverage for Aphakic Contact Lenses for Children
por: Kruger, Stacey J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8qo26olj3r24849pcpgk08d62j